A clinical approach to complex regional pain syndrome

Clinical Journal of Pain

Volumn 16, Issue 2 SUPPL., 2000, Pages

  Harden, R Norman ^a  

^a REHABILITATION INSTITUTE OF CHICAGO   (United States)

Author keywords

Complex Regional Pain Syndrome; CRPS; Empirical treatment; Guidelines; Reflex Sympathetic Dystrophy; RSD; Taxonomic and diagnostic issues

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANTICONVULSIVE AGENT; BRETYLIUM; CAPSAICIN; CARBAMAZEPINE; CLONIDINE; CYCLOOXYGENASE 2 INHIBITOR; DESIPRAMINE; DEXTROMETHORPHAN; DIZOCILPINE; EMLA; GABAPENTIN; GUANETHIDINE; KETAMINE; KETOPROFEN; LAMOTRIGINE; LIDOCAINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NIFEDIPINE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE AGONIST; PHENTOLAMINE; PHENYTOIN; SEROTONIN UPTAKE INHIBITOR; STEROID; TETRACYCLIC ANTIDEPRESSANT AGENT; TRICYCLIC ANTIDEPRESSANT AGENT;

ALGORITHM; ARTICLE; CAUSALGIA; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DRUG INDICATION; HUMAN; PAIN; PHYSIOTHERAPY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYMPATHETIC DYSTROPHY; SYMPTOMATOLOGY; VOCATIONAL REHABILITATION;

EID: 0034041480     PISSN: 07498047     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002508-200006001-00006     Document Type: Article

References (86)

1. Mitchell SW. Injuries of the nerves and their consequences. Philadelphia: JB Lippincott & Co, 1872.
2. Jänig W, Blumberg H, Boas RA, Campbell JN. The reflex sympathetic dystrophy syndrome: consensus statement and general recommendations for diagnosis and clinical research. In: Bond MR, Charlton JE, Woolf CJ, eds. Proceedings of the VIth World Congress on Pain. New York: Elsevier;1991:373-6.
3. Stanton-Hicks M, Jänig W, Hassenbusch S, et al. Reflex sympathetic dystrophy: changing concepts and taxonomy. Pain 1995;63: 127-33.
4. Jänig W, Stanton-Hicks M. Reflex sympathetic dystrophy: a reappraisal. In: Jänig W, Stanton-Hicks M, eds. Progress in pain research and management, vol. 6. Seattle: IASP Press:1996.
5. Bruehl S, Harden RN, Galer BS, et al. External validation of IASP diagnostic criteria for complex regional pain syndrome and proposed research diagnostic criteria. Pain 1999;81:147-54.
6. Wilson PR, Low PA, Bedder MD, et al. Diagnostic algorithm for complex regional pain syndromes. In: Jänig W, Stanton-Hicks M, eds. Progress in pain research and management, vol. 6. Seattle: IASP Press:1996.
7. Merskey H, Bogduk N. Classification of chronic pain: descriptions of chronic pain syndromes and definitions of pain terms, 2nd ed. Seattle: IASP Press;1994.
8. Galer BS, Bruehl S, Harden RN. IASP diagnostic criteria for complex regional pain syndrome: a preliminary empirical validation study. Clin J Pain 1998;14:48-54.
9. Harden RN, Bruehl S, Galer B, et al. Complex regional pain syndrome: are the IASP diagnostic criteria valid and sufficiently comprehensive? Pain 1999;83:211-9.
10. Price D, Bennett Gj, Rafii A. Psychophysiological observations on patients with neuropathic pain relieved by sympathetic block. Pain 1989;36:273-88.
11. Wilson PR. Sympathetically maintained pain: diagnosis, measurement, and efficacy of treatment. In: Stanton-Hicks M, ed. Pain and the sympathetic nervous system. Norwell, Massachusetts: Kluwer Academic Publishers;1990.
12. Schwartzman RJ, Kerrigan J. The movement disorder of reflex sympathetic dystrophy. Neurology 1990;40:57-61.
13. van der Laan L, Veldman P, Goris JA. Severe complications of reflex sympathetic dystrophy: infection, ulcers, chronic edema, dystonia, myoclonus. Arch Phys Med Rehabil 1998;79:424-9.
14. Rashiq S, Galer BS. Proximal myofascial dysfunction in complex regional pain syndrome: a retrospective prevalence study. Clin J Pain 1999;15:151-3.
15. Fowler CJ, Carrol MB, Burns D, et al. A portable system for measuring cutaneous thresholds for warming and cooling. J Neurol Neurosurg Psychiatry 1987;50:1211-25.
16. Yamitsky D, Sprecher E. Different algorithms for thermal threshold measurement. In: Biovi J, Hansson P, Linblum U, eds. Touch, temperature and pain in health and disease: mechanisms and assessments, vol. 3. Seattle: IASP Press;1994:105-12. The Progress in pain research and management series.
17. Hansson P, Lindblom U. Hyperalgesia assessed with quantitative sensory testing in patients with neurogenic pain. In: Willis WD, ed. Hvperalgesia and allodvnia. New York: Raven Press;1992:335-43.
18. Harden RN, Duc TA, Williams TR, et al. Norepinephrine and epinephrine levels in affected versus unaffected limbs in sympathetically maintained pain. Clin J Pain 1994;10:324-30.
19. Bruehl S, Lubenow T, Nath H, Ivankovich O. Validation of thermography in the diagnosis of reflex sympathetic dystrophy. Clin J Pain 1996;12:316-25.
20. Low P, Caskey P, Tuck R, et al. Quantitative sudomotor axon reflex test in normal and neuropathic subjects. Ann Neurol 1983; 14:573-80.
21. Werner R, Davidoff G, Jackson D, et al. Factors affecting the sensitivity and specificity of the three-phase technetium bone scan in the diagnosis of reflex sympathetic dystrophy syndrome in the upper extremity. J Hand Surg 1989;14A:520-3.
22. Lee GW, Weeks PM. The role of bone scintigraphy in diagnosing reflex sympathetic dystrophy. J Hand Surg 1995;20A:458-63.
23. Stanton-Hicks M, Baron R, Boas R, et al. Consensus report: complex regional pain syndromes: guidelines for therapy. Clin J Pain 1998;14:155-66.
24. Carlson LK, Watson HK. Treatment of reflex sympathetic dystrophy using the stress-loading program. J Hand Ther 1988;1:149-54.
25. Watson HK, Carlson L. Treatment of reflex sympathetic dystrophy of the hand with an active "stress loading" program. J Hand Surg 1987;12A:779-85.
26. Severens JL, Oerlemans HM, Weegels A, et al. Cost-effectiveness analysis of adjuvant physical or occupational therapy for patients with reflex sympathetic dystrophy. Arch Phys Med Rehabil 1999; 80:1038-43.
27. Starlanyl DJ. The Fibromyalgia Advocate. Oakland, CA: New Harbinger Publications;1999.
28. Kumar K, Toth C, Nath RK. Deep brain stimulation for intractable pain: a 15-year experience. Neurosurgery 1997;40:736-46.
29. Portwood MM, Lieberman JS, Taylor RG. Ultrasound treatment of reflex sympathetic dystrophy. Arch Phys Med Rhabil 1987;68: 116-7.
30. Haddox JD, Van Alstine D. Pharmacologic therapy for reflex sympathetic dystrophy. Phys Med Rehabil 1996;10:297-307.
31. McQuay HJ, Tramer M, Nye BA, et al. A systematic review of antidepressants in neuropathic pain. Pain 1996;68:217-27.
32. Max MB, Lynch SA, Muire J, et al. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med 1992;326:1250-6.
33. Max MB. Thirteen consecutive well-designed randomized trials show that antidepressants reduce pain in diabetic neuropathy and postherpetic neuralgia. Pain Forum 1995;4:248-53.
34. Watson CPN, Chipman M, Reed K, et al. Amitriptyline versus maprotiline in postherpetic neuralgia: a randomized, double-blind, crossover trial. Pain 1992;48:29-36.
35. Max MB, Kishore-Kumar R, Schafer SC, et al. Efficacy of desipramine in painful diabetic neuropathy: a placebo-controlled trial. Pain 1991;45:3-9.
36. Max MB, Kishore-Kumar R, Schafer SC, et al. Efficacy of desipramine in painful diabetic neuropathy: a placebo-controlled trial. Pain 1991;45:3-9.
37. Kingery WS. A critical review of controlled clinical trials for peripheral neuropathic and pain complex regional pain syndromes. Pain 1997;73:123-39.
38. Sindrup SH, Gram LF, Brosen K, et al. The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms. Pain 1990;42:135-44.
39. Sindrup SH, Bjerre U, Dejgaard A, et al. The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy. Clin Pharmacol Ther 1992;52:547-52.
40. McQuay H, Carroll D, Jadad A, et al. Anticonvulsant drugs for management of pain: a systematic review. Br Med J 1995;311: 1047-52.
41. Rowbotham M, Harden N, Stacey B, et al. Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. JAMA 1998;280:1837-42.
42. Backonja M, Beydoun A, Edwards KR, et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus. JAMA 1998;280:1831-6.
43. Mellick GA, Mellicy LB, Mellick Lb. Gabapentin in the management of reflex sympathetic dystrophy. J Pain Symptom Manage 1995;10:265-6.
44. Castro-Lopez JM, Tavares I, Coimbra A. GABA decreases in the spinal cord dorsal horn after peripheral neurectomy. Brain Res 1993;620:287-91.
45. Ibuki T, Hama AT, Wang XT, et al. Loss of GABA immunoreactivity in the spinal dorsal horn of rats with peripheral nerve injury and promotion of recovery by adrenal medullary grafts. Neurosci 1997;96:845-58.
46. Rosenberg JM, Harrell C, Ristie H, et al. The effect of gabapentin on neuropathic pain. Clin J Pain 1997;13:251-5.
47. Harden RN. Gabapentin: a new tool in the treatment of neuropathic pain. Acta Neurol Scand 1999;173(Suppl):43-7.
48. Matzner O, Devor M. Na+ conductance and the threshold for repetitive neuronal firing. Brain Res 1992;597:92-8.
49. Yaari Y, Devor M. Phenytoin suppresses spontaneous discharge in rat sciatic nerve neuromas. Neurosci Lett 1985;4:117-22.
50. Chadda V, Mathur M. Double-blind study of the effects of diphenylhydantoin sodium on diabetic neuropathy. J Assoc India 1978; 26:403-6.
51. Rull J, Quibrera R, Gonzalez-Millan H, Lozano CO. Symptomatic treatment of peripheral diabetic neuropathy with carbamazepine: double-blind crossover study. Diabetologia 1969;5:215-20.
52. Burchiel KJ. Carbamazepine inhibits spontaneous activity in experimental neuromas. Exp Neurol 1988;102:249-53.
53. Cohen M, Quintner J. Fibromyalgia syndrome, a protautology. Lancet 1993;342:906-9.
54. Gobel H, Stadler T. Treatment of post-herpes zoster pain with tramadol: results of an open pilot study versus clomipramine with or without levomepromazine. Drugs 1997;53(Suppl 2):34-9.
55. Jacobson M, Sharma YR, Cotlier E, Hollander JD. Diabetic complications in lens and nerve and their prevention by sulindac or sorbinil: two novel aldose reductase inhibitors. Invent Ophthalmol Vis Sci 1983;24:1426-9.
56. Parry GJ, Kozu H. Piroxicam may reduce the rate of progression of experimental diabetic neuropathy. Neurology 1990;40:1446-9.
57. Harden RN, Bruehl S. Point/counterpoint. The use of opioids in treatment of chronic pain: an examination of the ongoing controversy. J Back Musculoskeletal Rehabil 1997;9:155-80.
58. Harden RN, Bruehl S, Siegler J, Cole PA. Pain, psychological status, and functional recovery in chronic pain patients on daily opioids: a case comparison. J Back Musculoskeletal Rehabil 1997; 9:101-8.
59. Mao J, Price D, Caruso F, Mayer D. Oral administration of dextromethorphan prevents the development of morphine tolerance and dependence in rats. Pain 1996;67:361-8.
60. Mao J, Price DD, Mayer DJ, et al. Intrathecal MK-801 and local nerve anesthesia synergistically reduce nociceptive behaviors in rats with experimental peripheral mononeuropathy. Brain Res 1992;576:254-62.
61. Nelson KA, Park KM, Robinovitz E, et al. High dose oral dextromethorphan versus placebo in painful diabetic neuropathy and postherpetic neuralgia. Neurology 1997;48:1212-8.
62. Qian J, Brown SD, Carlton SM. Systemic ketamine attenuates nociceptive behaviors in a rat model of peripheral neuropathy. Brain Res 1996;715:51-62.
63. Tal M, Bennett GJ. Dextrorphan relieves neuropathic heat-evoked hyperalgesia. Neurosci Lett 1993;151:107-10.
64. Eide PK, Jorum E, Stubhaug A, et al. Relief of post-herpetic neuralgia with the N-methyl-D-aspartic acid receptor antagonist ketamine: A double-blind, cross-over comparison with morphine and placebo. Pain 1994;58:347-54.
65. Tracey DJ, Cunningham JE, Romm MA. Peripheral hyperalgesia in experimental neuropathy: mediation by alpha-2 adrenoreceptors on post-ganglionic sympathetic terminals. Pain 1995;60:217-327.
66. Bickerstaff DR, Kanis JA. The use of nasal calcitonin in the treatment of post-traumatic algodystrophy. Br J Rheum 1991;30:291-4.
67. Gobelet C, Meier JL, Schaffner W, et al. Calcitonin and reflex sympathetic dystrophy syndrome. Clin Rheum 1986;5:382-8.
68. Gobelet C, Waldburger M, Meier JL. The effect of adding calcitonin to physical treatment on reflex sympathetic dystrophy. Pain 1992;48:171-5.
69. Devers A, Galer BS. Topical lidocaine patch relieves a variety of neuropathic pain conditions: an open-label study. Clin J Pain, in press.
70. Attal N, Brasseur L, Chauvin M, Bouhassira D. Effects of single and repeated applications of a eutectic mixture of local anaesthetics (EMLA) cream on spontaneous and evoked pains in post-herpetic neuralgia. Pain 1999;81:203-9.
71. Bernstein JE, Korman NJ, Bickers DR, et al. Topical capsaicin treatment of chronic postherpetic neuralgia. J Am Acad Dermat 1989;21:265-70.
72. Group CS. Treatment of painful diabetic neuropathy with topical capsaicin: a multicenter, double-blind, vehicle-controlled study. Arch Intern Med 1991;151:2225-9.
73. Peikert A, Hentrich A, Echs G. Topical 0.025% capsaicin in chronic post-herpetic neuralgia: efficacy, predictors of response and long-term course. J Neurol 1991;238:452-6.
74. Simone DA, Ochoa J. Early and late effects o prolonged topical capsaicin on cutaneous sensibility and neurogenic vasodilation in humans. Pain 1991;47:285-94.
75. Stanton-Hicks M, Raj P, Racz G. Use of regional anesthetics for diagnosis of reflex sympathetic dystrophy and sympathetically maintained pain: a critical evaluation. In: Jänig W. Stanton-Hicks M, eds. Reflex sympathetic dystrophy: a reappraisal, vol. 6. Seattle: IASP Press, 1996:217-37.
76. Arner S. Intravenous phentolamine test: diagnostic and prognostic use in reflex sympathetic dystrophy. Pain 1991;46:17-22.
77. Raja SN, Treede RD, Davis KD, Campbell JN. Systemic alpha-adrenergic blockage with phentolamine: a diagnostic test for sympathetically maintained pain. Anesthesiol 1991;74:691-8.
78. Verdugo RJ, Campero M, Ochoa JL. Phentolamine sympathetic block in painful polyneuropathies. II. Further questioning of the concept of "sympathetically maintained pain." Neurology 1994;44: 1010-4.
79. Hannington-Kieff JG. Intravenous regional sympathetic blocks. In: Stanton-Hicks M, Jänig W, Boas RA, eds. Reflex sympathetic dystrophy. Boston: Kluwer Academic Publishers;1989:113-24.
80. Jadad AR, Carroll D, Glynn CJ, McQuay HJ. Intravenous regional sympathetic dystrophy: a systemic review and a randomized, double-blind crossover study. J Pain Symptom Manag 1995;10: 13-20.
81. Shir Y, Seltzer Z. Effects of sympathectomy in a model of causalgia from pain produced by partial sciatic nerve injury in rats. Pain 1991;45:205-13.
82. Kim SH, Chung JM. Effects of sympathectomy on a rat model of peripheral neuropathy. Pain 1993;55:85-92.
83. Baron R, Maier C. Reflex sympathetic dystrophy: skin blood flow, sympathetic vasoconstrictor reflexes and pain before and after surgical sympathectomy. Pain 1996;67:317-26.
84. Kumar D, Marshall HJ. Diabetic peripheral neuropathy: amelioration of pain with transcutaneous electrostimulation. Diabetes Care 1997;20:1702-5.
85. Meglio M, Cioni B, Prezioso A, Talamonti G. Spinal cord stimulation (SCS) in the treatment of postherpetic pain. Acta Neruchir Suppl (Wien) 1989;46:65-6.
86. Kemler MA, Barendse G, Van Kleef M, et al. Electrical spinal cord stimulation in reflex sympathetic dystrophy: retrospective analysis of 23 patients. J Neurosurg: Spine 1999;90:79-83.